News & Views in ... Diabetes

Citation metadata

Date: Mar. 2011
From: Therapy(Vol. 8, Issue 2)
Publisher: Future Medicine Ltd.
Document Type: Report
Length: 438 words
Lexile Measure: 1420L

Document controls

Main content

Article Preview :

New research from the University of Texas Southwestern, TX, USA, highlights glucagon control as an alternative to insulin therapy for Type 1 diabetes mellitus.

New findings from the University of Texas Southwestern Medical Center, TX, USA, suggest that simply eliminating the actions of one hormone could convert Type 1 diabetes into an asymptomatic disorder, negating the need for insulin injection.

Roger Unger, Professor of Internal Medicine at UT Southwestern, and colleagues had previously demonstrated that the benefits of insulin stem from its suppression of glucagon. Glucagon is normally released when the blood glucose level is low; however, patients with insulin deficiency have inappropriately high glucagon levels resulting in the...

Source Citation

Source Citation   

Gale Document Number: GALE|A252312101